Hypoxia causes gene expression changes largely through the induction of the HIF1 transcription factor, and many of these changes are thought to help adapt to the adverse environment where oxygen is limiting. One class of hypoxia-induced genes that have been extensively studied is the glycolytic enzymes. These molecules are thought to be necessary to maintain energy production when reduced oxygen will not support oxidative phosphorylation within the mitochondria. While glycolysis is important to cellular growth in hypoxia, we find that the mitochondrion does not just passively stop functioning. HIF-proficient cells actively reduce oxygen consumption in hypoxia while HIF-deficient cells do not. We therefore used expression profiling and data mining during the past funding cycle to identify hypoxia-induced proteins that are targeted to the mitochondria. These putative HIF-1 regulated mitochondrial proteins do not cause apoptosis, but our functional data supports the novel concept that they actively regulate mitochondrial activity in response to hypoxia. We therefore propose to address the following four questions in this application.
In specific aim 1, we will determine if HIF-dependent gene expression changes result in altered oxygen consumption in the mitochondria through the induction of target genes BNip3/L, and/or pyruvate dehydrogenase kinase 1 (PDK1) and/or hypoxia-induced gene 1 (HIG1).
In specific aim 2 we will test the hypothesis that pharmacologic reversal of these HIF-1 dependent changes will increase oxygen consumption, diminish intracellular oxygen concentrations, and result in sensitivity to oxygen-dependent therapies such as the hypoxic cytotoxins tirapazamine (TPZ).or dinitobenzamide mustard Pr-104.
In specific aim 3 we will ask if this pharmacologic treatment that makes tumors more hypoxic also makes them more aggressive and likely to metastasize. Lastly in specific aim 4 we hypothesize that we can identify additional novel regulators of hypoxic mitochondrial function through a screen of the yeast deletion library using growth in hypoxia on non- fermentable carbon source media. The proposed experiments will allow us to determine how these molecules contribute to hypoxic regulation of mitochondrial function, what they contribute to the growth of model tumors, and what impact they have on the tumor's response to oxygen-dependent therapy.
|Yuan, William; Jiang, Dadi; Nambiar, Dhanya K et al. (2017) Chemical Space Mimicry for Drug Discovery. J Chem Inf Model 57:875-882|
|Kariolis, Mihalis S; Miao, Yu Rebecca; Diep, Anh et al. (2017) Inhibition of the GAS6/AXL pathway augments the efficacy of chemotherapies. J Clin Invest 127:183-198|
|Castellini, Laura; Moon, Eui Jung; Razorenova, Olga V et al. (2017) KDM4B/JMJD2B is a p53 target gene that modulates the amplitude of p53 response after DNA damage. Nucleic Acids Res 45:3674-3692|
|VandeKopple, Matthew J; Wu, Jinghai; Baer, Lisa A et al. (2017) Stress-responsive HILPDA is necessary for thermoregulation during fasting. J Endocrinol 235:27-38|
|Aguilera, Todd A; Giaccia, Amato J (2017) Molecular Pathways: Oncologic Pathways and Their Role in T-cell Exclusion and Immune Evasion-A New Role for the AXL Receptor Tyrosine Kinase. Clin Cancer Res 23:2928-2933|
|Bobko, Andrey A; Evans, Jason; Denko, Nicholas C et al. (2017) Concurrent Longitudinal EPR Monitoring of Tissue Oxygenation, Acidosis, and Reducing Capacity in Mouse Xenograft Tumor Models. Cell Biochem Biophys 75:247-253|
|Vilalta, Marta; Hughes, Nicholas P; Von Eyben, Rie et al. (2017) Patterns of Vasculature in Mouse Models of Lung Cancer Are Dependent on Location. Mol Imaging Biol 19:215-224|
|Johnson, Rachelle W; Sowder, Miranda E; Giaccia, Amato J (2017) Hypoxia and Bone Metastatic Disease. Curr Osteoporos Rep 15:231-238|
|Chiou, Shin-Heng; Risca, Viviana I; Wang, Gordon X et al. (2017) BLIMP1 Induces Transient Metastatic Heterogeneity in Pancreatic Cancer. Cancer Discov 7:1184-1199|
|Sun, Ramon C; Koong, Albert; Giaccia, Amato et al. (2016) Measuring the Impact of Microenvironmental Conditions on Mitochondrial Dehydrogenase Activity in Cultured Cells. Adv Exp Med Biol 899:113-20|
Showing the most recent 10 out of 191 publications